Literature DB >> 21655952

Functional polymorphism of cyclooxygenase-2 gene (G-765C) in chronic obstructive pulmonary disease patients.

Tadeusz Pietras1, Janusz Szemraj, Michał Panek, Andrzej Witusik, Maciej Banasiak, Adam Antczak, Paweł Górski.   

Abstract

Cyclooxygenase two (COX-2) is an important enzyme metabolizing arachidonic acid. In contrast to constitutive cyclooxygenase one (COX-1), COX-2 is induced by proinflammatory factors. Polymorphism -765 G/C in COX-2-encoding gene promoter is associated with development of Alzheimer's disease, depression, carcinoma of the pancreas in smokers, breast cancer and rheumatoid arthritis. It is interesting whether the -765 G/C polymorphism in COX-2-encoding gene promoter can be associated with COPD, a disease which is inflammatory in character. It is highly probable as the breast and pancreas cancers, whose associations with the analyzed polymorphism have been studied, are smoking-dependent tumors. Additionally, tobacco smoke has been demonstrated to induce COX-2 in the lungs. The study group consisted of 122 COPD patients (48 females, 74 males). The control group consisted of 149 healthy nonsmoking subjects (83 females, 66 males). Polymerase chain reaction/restriction fragment length polymorphism was used for genotyping. A statistically significant difference in genotype distribution was observed as a result of the comparison between healthy subjects and patients with COPD. The distribution of alleles in both groups conformed with Hardy-Weinberg equilibrium. In the group of COPD patients, GG allele was found in 79 subjects, GC in 36, and CC in 7 subjects (F = 0.094, P = 0.296927); in the control group, 73 subjects had GG allele, 68--GC and 8--CC (F = 0.12728, P = 0.120265). The allele frequency revealed differences between those groups, attaining the level of statistical significance (χ(2) = 29.043, df = 2, P = 0.0000. The carriers of -765 G allele are at 1.53-fold higher risk of developing COPD. The presence of GG genotype does not increase significantly the risk of the disease. It is also noteworthy that the carriers of CC or GC genotypes are at significantly lower risk of developing COPD than the group of subjects with GG genotype.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21655952     DOI: 10.1007/s11033-011-0964-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  37 in total

Review 1.  COPD recent findings: impact on clinical practice.

Authors:  Annabelle Couillard; Jean François Muir; Daniel Veale
Journal:  COPD       Date:  2010-06       Impact factor: 2.409

2.  Cyclooxygenase-2 genotype and rheumatoid arthritis.

Authors:  Kyu Hoon Lee; Hee-Sang Kim; Ahmed El-Sohemy; Marilyn C Cornelis; Wan-Sik Uhm; Sang-Cheol Bae
Journal:  J Rheumatol       Date:  2006-07       Impact factor: 4.666

Review 3.  Systemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbidities.

Authors:  Helgo Magnussen; Henrik Watz
Journal:  Proc Am Thorac Soc       Date:  2009-12

Review 4.  Cyclooxygenases: structural and functional insights.

Authors:  Carol A Rouzer; Lawrence J Marnett
Journal:  J Lipid Res       Date:  2008-10-23       Impact factor: 5.922

Review 5.  Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases.

Authors:  Luisa Minghetti
Journal:  J Neuropathol Exp Neurol       Date:  2004-09       Impact factor: 3.685

6.  Interaction of cyclooxygenase-2 variants and smoking in pancreatic cancer: a possible role of nucleophosmin.

Authors:  Dan Zhao; Dongkui Xu; Xuemei Zhang; Li Wang; Wen Tan; Yongli Guo; Dianke Yu; Hui Li; Ping Zhao; Dongxin Lin
Journal:  Gastroenterology       Date:  2009-05       Impact factor: 22.682

7.  PTGS2 (COX-2) -765 G > C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma.

Authors:  Hela Ben Nasr; Karim Chahed; Noureddine Bouaouina; Lotfi Chouchane
Journal:  Mol Biol Rep       Date:  2007-10-30       Impact factor: 2.316

8.  Chronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase products.

Authors:  Mirella Profita; Angelo Sala; Anna Bonanno; Loredana Riccobono; Maria Ferraro; Stefania La Grutta; Giusy Daniela Albano; Angela Marina Montalbano; Mark Gjomarkaj
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-11-06       Impact factor: 5.464

9.  Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy.

Authors:  Sarah A Maher; Mark A Birrell; Maria G Belvisi
Journal:  Am J Respir Crit Care Med       Date:  2009-09-03       Impact factor: 21.405

10.  A functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian population.

Authors:  J Shi; N L Misso; D L Duffy; P J Thompson; M-A Kedda
Journal:  Clin Exp Allergy       Date:  2004-11       Impact factor: 5.018

View more
  5 in total

1.  Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages.

Authors:  Amanda Croasdell; Thomas H Thatcher; R Matthew Kottmann; Romain A Colas; Jesmond Dalli; Charles N Serhan; Patricia J Sime; Richard P Phipps
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-21       Impact factor: 5.464

2.  A case-control study and meta-analysis reveal the association between COX-2 G-765C polymorphism and primary end-stage hip and knee osteoarthritis.

Authors:  Wei Huang; Chen Deng; Feng Tian; Weilu Gao; Zhenfei Ding; Xianliang Rao; Zongsheng Yin
Journal:  J Clin Lab Anal       Date:  2018-02-17       Impact factor: 2.352

3.  Relationships of COX2 and MMP12 genetic polymorphisms with chronic obstructive pulmonary disease risk: a meta-analysis.

Authors:  Xiao-Ling Yu; Jun Zhang; Fei Zhao; Xiao-Ming Pan
Journal:  Mol Biol Rep       Date:  2014-09-11       Impact factor: 2.316

Review 4.  Breast cancer risk in rheumatoid arthritis: an update meta-analysis.

Authors:  Guo Tian; Jia-Ning Liang; Zhuo-Yun Wang; Dian Zhou
Journal:  Biomed Res Int       Date:  2014-10-27       Impact factor: 3.411

5.  Identification of differentially expressed genes and signaling pathways in chronic obstructive pulmonary disease via bioinformatic analysis.

Authors:  Xinwei Huang; Yunwei Li; Xiaoran Guo; Zongxin Zhu; Xiangyang Kong; Fubing Yu; Qiang Wang
Journal:  FEBS Open Bio       Date:  2019-09-29       Impact factor: 2.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.